Schroder Investment Management Group Bausch Health Companies Inc. Transaction History

Schroder Investment Management Group

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $9.15 Million - $11.8 Million	-423,684 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $352,820 - $445,013	15,340 Added 3.76%	423,684 $14.8 Million
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $554,826 - $661,422	20,227 Added 5.21%	408,344 $14.9 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $5.84 Million - $9.39 Million	-273,057 Reduced 41.3%	388,117 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $8.49 Million - $11.7 Million	554,296 Added 518.62%	661,174 $17.5 Million
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $206,832 - $279,807	13,900 Added 14.95%	106,878 $2.25 Million
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $86,621 - $133,479	6,508 Added 7.53%	92,978 $2.31 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $880,667 - $2.05 Million	-67,848 Reduced 43.97%	86,470 $1.78 Million
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $1.39 Million - $2.35 Million	73,770 Added 91.59%	154,318 $6 Million
Q3 2019 Nov 12, 2019	BUY	$20.88 - $25.66 $1.02 Million - $1.25 Million	48,888 Added 154.42%	80,548 $2.32 Million
Q2 2019 Aug 08, 2019	SELL	$20.52 - $26.45 $629,348 - $811,221	-30,670 Reduced 49.21%	31,660 $1.05 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $5.8 Million - $7.54 Million	-286,875 Reduced 82.15%	62,330 $2.06 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $858,309 - $1.38 Million	48,657 Added 16.19%	349,205 $8.82 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $6.2 Million - $7.72 Million	300,548 New	300,548 $9.97 Million

267

252M

5.12M

9.42M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.3B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.